|
Medicines Co Shares Up 40.2% Since SmarTrend's Buy Recommendation (MDCO)
Mar 06, 2013 (SmarTrend(R) Spotlight via COMTEX) --
SmarTrend identified an Uptrend for Medicines Co (NASDAQ:MDCO) on December 19th, 2012 at $22.52. In approximately 3 months, Medicines Co has returned 40.23% as of today's recent price of $31.58.
In the past 52 weeks, shares of Medicines Co have traded between a low of $12.33 and a high of $33.25 and are now at $31.58, which is 156% above that low price. The 200-day and 50-day moving averages have moved 0.62% higher and 1.92% higher over the past week, respectively.
The Medicines Company develops products that improve specialized care. The Company markets Angiomax, an anticoagulant approved in the United States and other countries for use in patients undergoing coronary angioplasty procedures.
SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Medicines Co shares.Log in and add Medicines Co (MDCO) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.
Write to Chip Brian at cbrian@mysmartrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup
[ Back To Technology News's Homepage ]
|
Internet Telephony Magazine
Click here to read latest issue
CUSTOMER 
Cloud Computing Magazine
Click here to read latest issue
M2M Evolution Magazine
Call Center/CRM
Info Tech 
IP Communications 
Mobile 
Green 
Satellite 
Robotics 
